Ultralife Corporation (ULBI)

Ultralife Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	7.2	-0.12	-0.23	5.23	5.21
Depreciation & Amortization	3.91	4.46	3.54	2.94	2.75
Share-Based Compensation	0.53	0.78	0.67	0.94	0.75
Other Operating Activities	-9.71	-6.38	0.35	12.61	-11.67
Operating Cash Flow	1.93	-1.26	4.33	21.72	-2.97
Operating Cash Flow Growth	-	-	-80.09%	-	-
Capital Expenditures	-2.55	-1.68	-2.81	-2.98	-6.28
Acquisitions	0	0	-23.52	0	-25.25
Investing Cash Flow	-2.55	-1.68	-26.33	-2.98	-31.53
Share Issuance / Repurchase	1.25	0.12	0.4	0.24	-1.03
Debt Issued / Paid	4.25	0.42	19.39	-15.84	17.16
Other Financing Activities	-0.01	-0.02	-0.15	-0.09	-0.01
Financing Cash Flow	5.49	0.52	19.64	-15.69	16.12
Exchange Rate Effect	-0.3	-0.28	0.13	0.2	-0.15
Net Cash Flow	4.57	-2.7	-2.24	3.25	-18.53
Free Cash Flow	-0.62	-2.94	1.51	18.74	-9.25
Free Cash Flow Growth	-	-	-91.94%	-	-
Free Cash Flow Margin	-0.39%	-2.23%	1.54%	17.40%	-8.66%
Free Cash Flow Per Share	-0.04	-0.18	0.09	1.18	-0.59

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).